2025 Media Partners
Take a look at the media partners who decided to support the 9th IPF Summit. If you are interested in a media partnership please contact info@hansonwade.com.
Fibrosis is a devastating interstitial disease that can affect any organ and is responsible for up to 45% of all deaths in the industrialized world. A large proportion of these deaths could be prevented, but improving prevention and treatment outcomes requires accurate diagnosis, the development of effective and precise treatment modalities and a better understanding of the socioeconomic factors that affect Fibrosis incidence, prevalence and mortality.
Fibrosis aims to provide a unique forum through which the Fibrosis community will learn about the latest, most significant fibrosis-related advances across the life, physical, applied and social sciences. Areas of interest include fundamental, preclinical research that furthers our understanding of the mechanisms underlying scar initiation, propagation and progression; work aiming to translate this knowledge to the clinic by focusing on new approaches for the development and delivery of diagnostic and therapeutic modalities; clinical studies informing fibrosis diagnosis, treatment and prevention; and new ways of understanding the global societal impact of fibrosis.
In addition to publishing original research, Fibrosis will publish Comments, Reviews, News & Views, Features, Case Reports and Correspondence of high significance across the range of disciplines relating to fibrosis research.
Topics covered in the journal include:
- Fibrosis biology, encompassing fibrogenic and scar-suppressive mechanisms that deregulate molecular pathways and cellular processes, including scar-initiating cells/fibrocyte
- Fibrosis genetics and genomics, including functional genomics and the mechanisms underlying genome integrity, genomic instability and mutation
- Scar evolution and heterogeneity
- Scar–host interactions, including the scar microenvironment (molecular, cellular, physical) and systemic effects
- Scar immunology and immunotherapy
- Therapy, including design and delivery, targeted, combination and precision therapy and the study of therapy resistance
- Clinical work that informs Fibrosis diagnosis, treatment and prevention
- Fibrosis models and methodology to investigate, diagnose and treat Fibrosis
- Systems biology, including large-scale and single-cell omics and multi-omics approaches to characterise and study Fibrosis
- Social, ethical and policy issues relating to Fibrosis research, prevention, diagnosis and treatment
Journal Contact E-mail: fibrosis@sciepublish.org
BioPharma Asia aims to keep its readers abreast of all developments in Manufacturing, Development, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters associated with only end-user companies. So, ensuring the information will always be guaranteed to remain timely, informative, and unbiased.
Website: ww.biopharma-asia.com